12 Health Care Stocks Moving In Monday's After-Market Session

BenzingaOct 28 16:30 ET

Express News | NextCure Shares Are Trading Lower. The Company Announced Results From Its Phase 1b Study of NC410

BenzingaSep 16 08:51 ET

Express News | NextCure Presented Results of the Phase 1B Study of Nc410 in Combination With Pembrolizumab at Esmo 2024

ReutersSep 16 08:05 ET

Is NextCure (NASDAQ:NXTC) In A Good Position To Deliver On Growth Plans?

Yahoo FinanceSep 3 07:16 ET

NextCure Price Target Maintained With a $4.00/Share by Needham

Dow JonesAug 2 08:21 ET · Ratings

Piper Sandler Maintains NextCure(NXTC.US) With Buy Rating, Maintains Target Price $3

Moomoo NewsAug 2 07:31 ET · Ratings